| 1 |
35356749 | circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis. | 2022 |
3 |
| 2 |
35433741 | Isoliquiritin Ameliorates Cisplatin-Induced Renal Proximal Tubular Cell Injury by Antagonizing Apoptosis, Oxidative Stress and Inflammation. | 2022 |
1 |
| 3 |
35533545 | Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury. | 2022 Jul |
1 |
| 4 |
35624727 | Cisplatin-Induced Reproductive Toxicity and Oxidative Stress: Ameliorative Effect of Kinetin. | 2022 Apr 28 |
1 |
| 5 |
32875568 | Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function. | 2021 Jan 1 |
1 |
| 6 |
32930970 | Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis. | 2021 Feb |
1 |
| 7 |
33345849 | IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. | 2021 Mar 5 |
2 |
| 8 |
33727094 | Cisplatin-induced activation and functional modulation of satellite glial cells lead to cytokine-mediated modulation of sensory neuron excitability. | 2021 Jul |
2 |
| 9 |
33813381 | The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line. | 2021 Apr |
1 |
| 10 |
34094941 | lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. | 2021 |
2 |
| 11 |
34132362 | miR‑375/Yes‑associated protein axis regulates IL‑6 and TGF‑β expression, which is involved in the cisplatin‑induced resistance of liver cancer cells. | 2021 Aug |
2 |
| 12 |
34139285 | Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. | 2021 Oct 10 |
1 |
| 13 |
34262937 | Network-Based Expression Analyses and Experimental Verifications Reveal the Involvement of STUB1 in Acute Kidney Injury. | 2021 |
1 |
| 14 |
34375503 | ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells. | 2021 Sep |
2 |
| 15 |
31497913 | Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-κB signaling maintained macrophage inflammation. | 2020 Jan |
1 |
| 16 |
31983246 | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. | 2020 Nov |
1 |
| 17 |
32127934 | Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression. | 2020 |
1 |
| 18 |
32434541 | Cisplatin treatment induced interleukin 6 and 8 production alters lung adenocarcinoma cell migration in an oncogenic mutation dependent manner. | 2020 May 20 |
2 |
| 19 |
30670152 | Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells. | 2019 Mar |
3 |
| 20 |
31570278 | Potential role of TET2 in gastric cancer cisplatin resistance. | 2019 Nov |
1 |
| 21 |
29059160 | IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. | 2018 Feb 15 |
1 |
| 22 |
29545331 | Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer. | 2018 Jun |
2 |
| 23 |
29731768 | TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production. | 2018 |
2 |
| 24 |
29761938 | Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1. | 2018 May 15 |
2 |
| 25 |
29767234 | MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway. | 2018 Aug |
2 |
| 26 |
29844821 | Tumor-derived mesenchymal-stem-cell-secreted IL-6 enhances resistance to cisplatin via the STAT3 pathway in breast cancer. | 2018 Jun |
2 |
| 27 |
29861860 | FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. | 2018 May 18 |
1 |
| 28 |
28182789 | Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway. | 2017 |
1 |
| 29 |
28356286 | Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. | 2017 Oct 1 |
1 |
| 30 |
28388577 | IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells. | 2017 Jun 13 |
2 |
| 31 |
28454469 | Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. | 2017 Apr |
1 |
| 32 |
28473707 | DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer. | 2017 May 4 |
1 |
| 33 |
28878571 | Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. | 2017 |
8 |
| 34 |
28978005 | Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer. | 2017 Sep 15 |
1 |
| 35 |
26439246 | Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy. | 2016 Jan |
1 |
| 36 |
26597704 | Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade. | 2016 Feb |
2 |
| 37 |
26759169 | Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. | 2016 Jan 12 |
1 |
| 38 |
27009878 | Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer. | 2016 Jun |
7 |
| 39 |
27108527 | Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinoma. | 2016 Jun |
8 |
| 40 |
27206315 | Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. | 2016 Sep 1 |
1 |
| 41 |
27216197 | STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs. | 2016 Jul 1 |
1 |
| 42 |
27287412 | IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling. | 2016 Sep |
1 |
| 43 |
27824145 | Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis. | 2016 Nov 8 |
3 |
| 44 |
26193055 | Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins. | 2015 Oct 15 |
1 |
| 45 |
26313152 | IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules. | 2015 Sep 29 |
4 |
| 46 |
24286513 | Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines. | 2014 Feb |
2 |
| 47 |
24709421 | Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. | 2014 Feb |
2 |
| 48 |
24796665 | Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines. | 2014 Jun 27 |
1 |
| 49 |
24988892 | Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation. | 2014 Sep |
1 |
| 50 |
25272046 | Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1. | 2014 |
1 |